Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) EBT Margin (2023 - 2025)

Zenas BioPharma (ZBIO) has 2 years of EBT Margin data on record, last reported at 337.78% in Q1 2025.

  • For Q1 2025, EBT Margin changed N/A year-over-year to 337.78%; the TTM value through Sep 2025 reached 191.59%, changed N/A, while the annual FY2024 figure was 87.18%, 13914.0% up from the prior year.
  • EBT Margin reached 337.78% in Q1 2025 per ZBIO's latest filing, down from 2174.84% in the prior quarter.
  • Across five years, EBT Margin topped out at 2174.84% in Q4 2024 and bottomed at 337.78% in Q1 2025.